# Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)

> **NCT00705081** · — · COMPLETED · sponsor: **Organon and Co** · enrollment: 453 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** statin

## Key facts

- **NCT ID:** NCT00705081
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 453 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705081, "Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00705081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*